⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6782280 | 0.73 | — | — | |
| SCHEMBL134356 | 0.73 | — | — | |
| SCHEMBL22448806 | 0.73 | — | — | |
| SCHEMBL952152 | 0.71 | ALDH1A1 (0.39) | — | |
| SCHEMBL18384525 | 0.71 | — | — | |
| SCHEMBL12888006 | 0.71 | — | — | |
| SCHEMBL601260 | 0.69 | — | — | |
| SCHEMBL237113 | 0.69 | ALDH1A1 (0.37) | — | |
| SCHEMBL955170 | 0.67 | — | — | |
| SCHEMBL15177569 | 0.67 | ALDH1A1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2694 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727936-A2 | METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF | Alexion Pharmaceuticals, Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| CN-120136785-A | Synthesis method of 1-cyclopropyl-6, 7-difluoro-1, 4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid n-propyl ester | 江苏吉贝尔药业股份有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-120004790-A | Synthesis method of spiro oxindole, ke Nayin and yohimbine alkaloid and derivatives thereof | 中国科学院昆明植物研究所 | 2025-05-16 | — | — | CN | claimed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | claimed |
| US-20250066296-A1 | METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF | ALEXION PHARMACEUTICALS, INC. (US) | 2025-02-27 | — | — | US | claimed |
| WO-2024259085-A2 | METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF | ALEXION PHARMACEUTICALS, INC. (US) | 2024-12-19 | — | — | WO | claimed |
| EP-4448490-A2 | METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF | Alexion Pharmaceuticals, Inc. (US) | 2024-10-23 | — | — | EP | claimed |
| WO-2023114200-A2 | METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF | ALEXION PHARMACEUTICALS, INC. (US) | 2023-06-22 | — | — | WO | claimed |
| US-11274081-B2 | Process for the synthesis of ivacaftor | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2022-03-15 | — | — | US | claimed |
| US-20200407364-A1 | FUSED BICYCLIC COMPOUNDS | AKARNA THERAPEUTICS LTD (GB) | 2020-12-31 | — | — | US | claimed |
| EP-1736475-A1 | Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates | FERRER INTERNACIONAL, S.A. (ES) | 2006-12-27 | — | — | EP | claimed |
| US-20050209257-A1 | 5-Protected aminopyrimidine compound, production method thereof and intermediate therefor | AJINOMOTO CO., INC. (JP) | 2005-09-22 | — | — | US | claimed |
| EP-1577303-A1 | 5-protected aminopyrimidine compound, production method thereof and intermediate thereof | Ajinomoto Co., Inc. (JP) | 2005-09-21 | — | — | EP | claimed |
| US-6780993-B1 | USEFUL AS INHIBITORS FOR 5'-DEOXY-5'- METHYLTHIOADENOSINE PHOSPHORYLASE (MTAP)AND IN TREATING CANCERS | BIOCRYST PHARMACEUTICALS, INC. | 2004-08-24 | — | — | US | claimed |
| US-6100399-A | Synthesis for 4-aryl-5-pyrimidine imidazole substituted compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2000-08-08 | — | — | US | claimed |
| EP-1019393-A1 | NOVEL SYNTHESIS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-07-19 | — | — | EP | claimed |
| EP-1019393-A4 | NOVEL SYNTHESIS | SMITHKLINE BEECHAM CORP (US) | 2000-07-19 | — | — | EP | claimed |
| WO-1997023479-A1 | NOVEL SYNTHESIS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-07-03 | — | — | WO | claimed |
| EP-0168037-B1 | 1-6-NAPHTHYRIDIN-2(1H)-ONES USEFUL AS CARDIOTONICS | STERLING DRUG INC. (US) | 1990-02-07 | — | — | EP | claimed |
| EP-0168037-A2 | 1-6-Naphthyridin-2(1H)-ones useful as cardiotonics | STERLING DRUG INC. (US) | 1986-01-15 | — | — | EP | claimed |